Staphcoccomycin (SCM) is a new member of the basic macrolide family of antibiotics which was isolated from the fermentation broth of Streptomyces sp. AS-NG-16. The production, purification and determination of physical and chemical properties of this novel metabolite have been completed. Comparison of the mass fragmentation patterns of SCM and its peracetate with those of angolamycin peracetate suggested a des-mycarosyl derivative of angolamycin.
Moreover, the molecular ion peak (m/e 771) corresponded to C9H,5NOI, and the 'H-NMR of SCM was also consistent with the proposed structure. 
SCM producing organism
Streptomyces sp. AS-NG-16 was allowed to grow on starch-nitrate agar medium at 28`C. The morphological, physiological and biochemical characteristics of the organism were investigated according to the system described by WAKSMAN".
Production and isolation of SCM Streptomyces• sp. AS-NG-16 was grown in 14-liter fermentors (New Brunswick) aerated with I vol. air/1 vol. medium/I min. The temperature was kept at 28°C with a stirring shaft rate of 600 r.p.m. The production medium has the following composition (g/100 ml): Soluble starch 2.0; soybean flower 1.0; NaNO, 0.2; K_HPO, 0.1; MgSO,•7H,O 0.05; KCI 0.05 and FeSO4.5H_O 0.00075; initial pH 7.0. The antibiotic production reached its maximum level (8 mg/liter) after 72 hours of fermentation after which the fermentation broth was filtered and extracted with 30" v/v of ethyl acetate -chloroform mixture (1: 1, v/v) at pFl 7.0. The extract was evaporated under vacuum to dryness and the residue was redissolved in a minimum amount of chloroform. Petroleum ether (b.p. 40-60'C) was then added until turbidity started and then left in refrigerator overnight. The precipitate was harvested by centrifugation as a yellow powder.
Purification of SCM The crude preparation was chromatographed on preparative T.L.C. plates (silica gel GF,;,,) using the lower phase of the following developing mixture: CHCI:, -McOH -7° NH,OH (4: 1 : 2, v/v/s ). Two biologically active components were separated in the ratio of 9: 1. The spots were scrapped off the plate, extracted with acetone and then evaporated to dryness. The residue was dissolved in chloroform and precipitated with petroleum ether (40'60'C).
The major component (Rf 0.32) was purified further using the same T.L.C. technique.
The UV, IR, 'H-NMR and MS analysis were carried out and the results are given below. The bi vivo evaluation of SCM is given in Tables 2 and 3 . The Rf values of SCM on silica gel GF23} using different developing solvents were: 0.1 for benzeneacetone 3a) and its peracetyl derivative (Fig. 3b) are given in Charts la and lb respectively, while those of the 'H-NMR signals (Fig. 4) IR absorption at 1720 cm -1 (-C-O) and low nitrogen content (less than 2%) suggest that SCM is a basic macrolide antibiotic possessing the epoxy-enone structure in the aglycone moiety. As described later, the mass fragmentation pattern supported this assumption. The presence of two anomeric protons at 8 4.36 and 4.57 in the 1H-NMR spectrum of SCM (Fig. 4) shows that SCM contains two sugar moieties. Mass spectrometry is often used for the elucidation of the structure of macrolide antibiotics.
In the mass spectrum of a macrolide, a pair of fragmentation peaks appearing at regions lower than about m/e 200 with 16 mass units difference are diagnostically important. These peaks are ascribed to a sugar molecule and the 16 mass units difference is due to the oxygen atom connecting the glycoside.
The two pairs of peaks at mle 175 and 191, and mle 158 and 174 shown in the mass spectrum of SCM (Fig. 3a) are therefore ascribed to the two sugar moieties suggested from the 1H-NMR spectrum. sugars correspond to a formula of C8H1,NO: rhodosamine in the anthracyclines, desosarnine in many macrolides, angolosamine in angolamycin and megosamine in megalomycin. Among these, desosamine may probably be differentiated from the sugar of SCM, because, in the 'H-NMR spectrum, an anomeric proton due to desosamine would appear at 6 as a doublet with J,,2=7. Sugars other than those given above could not be distinguished from the sugar in SCM via physicochemical means.
However, among the numerous macrolide antibiotics, angolamycin (II) alone contains CBH1605
(mycinose) and C81117NO, (angolosamine) in addition to mycarose (C,H1{0a). Accordingly, the mass fragmentation patterns (Chart la) of SCM and its peracetate (Chart lb) were compared with that of angolamycin peracetate reported in the literature". It was found that, by assuming the structure of SCM (I) as des-mycarosyl derivative of angolamycin, the molecular ion peaks (m/e 771) corresponded to C39H65N014, and the mass fragmentation pattern of SCM was consistent as shown in Chart 1. 'H -NMR signals of SCM were also consistent with the proposed structure as shown in Chart 2 . Hitherto, the basic macrolide whose structure was shown by structure (I) has not been reported. It may be necessary to refer to shincomycin B which was presumably produced along with shincomycin A (angolamycin). The reported IR spectrum of shincomycin B7' is very similar to that of SCM except for minor differences. However, it was impossible to compare the identity Activity against Gram-negative bacteria was not observed at 100 mcg/ml.
Serial agar dilution method in heart infusion agar was used.
The plates were incubated at 37'C for 48 hours. S. aureus 252 R : resistant to tetracycline, and kanamycin.
S. aureus 199 R: resistant to tetracycline, streptomycin, kanamycin, neomycin, penicillin, chloramphenicol, erythromycin, and other macrolides.
S. aureus 664 R: resistant to tetracycline. S. epidermidis 10131 R: resistant to leucomycin. Observation: 1 week.
